Cargando…

Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture

Immunoglobulin D multiple myeloma is a rare type of multiple myeloma that usually presents as bone pain, fatigue, or weight loss. We report a case of immunoglobulin D multiple myeloma in a 53-year-old Caucasian male patient with previous medical history of anaplastic oligodendroglioma status post-su...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Hadidi, Samer, Katato, Khalil, Bachuwa, Ghassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422729/
https://www.ncbi.nlm.nih.gov/pubmed/28512409
http://dx.doi.org/10.1159/000466687
_version_ 1783234836843986944
author Al Hadidi, Samer
Katato, Khalil
Bachuwa, Ghassan
author_facet Al Hadidi, Samer
Katato, Khalil
Bachuwa, Ghassan
author_sort Al Hadidi, Samer
collection PubMed
description Immunoglobulin D multiple myeloma is a rare type of multiple myeloma that usually presents as bone pain, fatigue, or weight loss. We report a case of immunoglobulin D multiple myeloma in a 53-year-old Caucasian male patient with previous medical history of anaplastic oligodendroglioma status post-surgical resection who was evaluated for back pain while mowing the lawn. His physical examination showed tenderness over the lower thoracic vertebrae with no sensory or motor impairment. Initial lab investigations showed normocytic anemia and hypercalcemia with low parathyroid hormone. Magnetic resonance imaging of thoracic spine with and without contrast showed acute pathological fracture of the T12 vertebral body with enhancing soft tissue which extended into the left ventral epidural space and left T11–T12 neural foramen. Serum protein electrophoresis showed abnormal protein band in the gamma globulin. Free light chain assay showed serum free kappa which was elevated at 3,090.0 mg/L (reference range 3.3–19.4 mg/L). Immunoglobulin D was elevated at 566.0 mg/dL (reference range <15.3 mg/dL). The patient was successfully treated with standard chemotherapy and autologous peripheral blood stem cell transplant with complete remission 3 years after starting treatment. Advancement in the treatment of immunoglobulin D multiple myeloma urge clinicians to offer their patients new treatment options especially as of the earlier presentation of this subtype of multiple myeloma and the previous reports of worse prognosis.
format Online
Article
Text
id pubmed-5422729
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-54227292017-05-16 Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture Al Hadidi, Samer Katato, Khalil Bachuwa, Ghassan Case Rep Oncol Case Report Immunoglobulin D multiple myeloma is a rare type of multiple myeloma that usually presents as bone pain, fatigue, or weight loss. We report a case of immunoglobulin D multiple myeloma in a 53-year-old Caucasian male patient with previous medical history of anaplastic oligodendroglioma status post-surgical resection who was evaluated for back pain while mowing the lawn. His physical examination showed tenderness over the lower thoracic vertebrae with no sensory or motor impairment. Initial lab investigations showed normocytic anemia and hypercalcemia with low parathyroid hormone. Magnetic resonance imaging of thoracic spine with and without contrast showed acute pathological fracture of the T12 vertebral body with enhancing soft tissue which extended into the left ventral epidural space and left T11–T12 neural foramen. Serum protein electrophoresis showed abnormal protein band in the gamma globulin. Free light chain assay showed serum free kappa which was elevated at 3,090.0 mg/L (reference range 3.3–19.4 mg/L). Immunoglobulin D was elevated at 566.0 mg/dL (reference range <15.3 mg/dL). The patient was successfully treated with standard chemotherapy and autologous peripheral blood stem cell transplant with complete remission 3 years after starting treatment. Advancement in the treatment of immunoglobulin D multiple myeloma urge clinicians to offer their patients new treatment options especially as of the earlier presentation of this subtype of multiple myeloma and the previous reports of worse prognosis. S. Karger AG 2017-03-29 /pmc/articles/PMC5422729/ /pubmed/28512409 http://dx.doi.org/10.1159/000466687 Text en Copyright © 2017 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Al Hadidi, Samer
Katato, Khalil
Bachuwa, Ghassan
Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture
title Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture
title_full Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture
title_fullStr Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture
title_full_unstemmed Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture
title_short Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture
title_sort immunoglobulin d multiple myeloma presenting as spontaneous fracture
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422729/
https://www.ncbi.nlm.nih.gov/pubmed/28512409
http://dx.doi.org/10.1159/000466687
work_keys_str_mv AT alhadidisamer immunoglobulindmultiplemyelomapresentingasspontaneousfracture
AT katatokhalil immunoglobulindmultiplemyelomapresentingasspontaneousfracture
AT bachuwaghassan immunoglobulindmultiplemyelomapresentingasspontaneousfracture